Collectively, these results demonstrate that the abnormal expression of HAT1 promotes PCa and CRPC tumorigenesis by upregulating AR expression, and inhibition of HAT1 expression may shed new lights on CRPC treatment. Here, AR is linked to posterior cortical atrophy.